We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 897

New False Ad Suits: Headphones, Pasta Sauce, and Energy Drinks
  • Manatt Phelps & Phillips LLP
  • USA
  • November 8 2018

Recent false advertising lawsuits run the gamut from sweaty Bose headphones to pasta sauce with preservatives to a battle between energy drink


HHS Proposes Disclosure of Drug Prices in TV Advertising, But Fight Over Authority On the Horizon
  • Arent Fox LLP
  • USA
  • October 29 2018

The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or


FDA Warns Against Sales Representative’s “False and Misleading” Oral Statements Regarding Prescription Medicine
  • Drinker Biddle & Reath LLP
  • USA
  • October 25 2018

The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) sent an untitled letter to Eisai Inc. on October 11, 2018, based


FDA Draft Guidance on Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • October 24 2018

On October 17, 2018, FDA issued draft guidance on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling


A new normal in the pharmaceutical industry: How to fight back when your competitor can't stop fibbing
  • Hogan Lovells
  • USA
  • October 22 2018

Speaking in September at a discussion hosted by the Alliance for a Stronger FDA, Dr. Janet Woodcock provided some candid insight into FDA's


“I’ll Be Back;” Ninth Circuit Gives Arnold Schwarzenegger-Branded Supplement Purchasers Another Shot to Pursue UCL, FAL, CLRA and Warranty Claims
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • October 18 2018

In Durnford v. MusclePharm Corp., plaintiff Durnford asserted that the company’s “Arnold Schwarzenegger Series Iron Mass” supplements are falsely


Where's the beef?
  • Frankfurt Kurnit Klein & Selz PC
  • USA
  • October 17 2018

MusclePharm produces a line of nutritional supplements, including the “Arnold Schwarzenegger Series Iron Mass” supplement. The supplement is marketed


FDA's Drug Centers Release New Draft Guidance on Quantitative Info in Consumer-Directed Ads
  • Mintz
  • USA
  • October 17 2018

In the first new guidance document from FDA in several years specific to the subject of direct-to-consumer (DTC) promotion of prescription drugs and


Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads
  • Mintz
  • USA
  • October 17 2018

The Trump Administration is moving full speed ahead with its proposals under the Blueprint to Lower Drug Prices (the “Blueprint”). Earlier this week


Infrared Protection Claims Rub NAD the Wrong Way
  • Baker & Hostetler LLP
  • USA
  • October 5 2018

Bayer HealthCare, a manufacturer of sunscreen products, brought complaints against competitor Sea & Ski before the National Advertising Division (NAD) in September...